PA
CLB icon

Pinnacle Associates’s Core Laboratories CLB Stock Holding History

Pinnacle Associates’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,805
Closed -$214K – 743
2022
Q2 		$214K Sell
10,805
-5,220
-33% -$139K ﹤0.01% 694
2022
Q1 		$507K Buy
+16,025
New +$449K 0.01% 559

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pinnacle Associates's CLB Position: Q3 2022 in Review

Pinnacle Associates sold out of Core Laboratories (CLB) in Q3 2022, closing a stake of 10,805 shares — an estimated $214K sold.

Pinnacle Associates first reported a position in CLB in Q1 2022 and held it in 2 quarters. The position peaked at $507K in Q1 2022. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

  • Pinnacle Associates reported no remaining Core Laboratories position as of Q3 2022 after selling out during the quarter.
  • Pinnacle Associates sold 10,805 Core Laboratories shares in Q3 2022, an estimated $214K.
  • Pinnacle Associates first reported a position in Core Laboratories in Q1 2022 and held it in 2 quarters.
  • Pinnacle Associates's Core Laboratories position peaked at $507K in Q1 2022.
  • 162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on Pinnacle Associates's 13F filing for Q3 2022, filed 1 Nov 2022.